Fatigue and Inspiratory Muscles Training in Patients With Multiple Sclerosis
NCT ID: NCT02726672
Last Updated: 2018-11-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
46 participants
INTERVENTIONAL
2016-02-29
2018-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Inspiratory Muscle Training in Multiple Sclerosis
NCT03887546
Effects of a 12-week Respiratory Muscles Training Program in Persons With Relapsing- Remitting Multiple Sclerosis
NCT02104492
Effect of Functional Inspiratory Muscle Training in Patients with Multiple Sclerosis
NCT06672770
Effects of Ten-Weeks Power Training on Neuromuscular Performance, Heart Rate Variability, Sleep Quality and Mobility in Persons With Multiple Sclerosis
NCT04276324
Effects of Ten-Weeks Progressive Resistance Training on Neuromuscular Performance, Mobility, Heart Rate Variability and Sleep Quality in Persons With Multiple Sclerosis
NCT04452760
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Respiratory rehabilitation
Respiratory rehabilitation: Powerbreathe training of the inspiratory muscles at home twice a day (2 sessions of 30 inspirations / day) during 10 weeks
respiratory rehabilitation using Powerbreathe
10 minutes 2 times a day : 30 inspirations per session during 10 weeks
control group
No respiratory rehabilitation
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
respiratory rehabilitation using Powerbreathe
10 minutes 2 times a day : 30 inspirations per session during 10 weeks
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Aged between 18 and 65 years
* Patients able to maintain the Powerbreathe
* Not to have had a flare-up since at least 6 weeks
* Patients at least 4 weeks since a corticoid bolus
* Patients at least 6 weeks since a botulinum toxin injection
* Patients at least 4 weeks since a pulmonary infection
* Questionnaire EMIF-SEP \>= 55
* Patients given their informed consent
* Patients who benefit or are affiliated to a social security regimen
Exclusion Criteria
* Patients with respiratory disorders other than those induced by multiple sclerosis
* Patients with orthopedic, cardiac, and rheumatologic invalidating antecedents
* Patients with comprehension or cognitive disorders impeding the realization of rehabilitation
* Pregnant women
* Patients under legal guardianship, or safeguard of justice
* Patients participating or planning participate within the 3 months of the study to another clinical research project
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Lille Catholic University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Cécile Donzé, MD
Role: PRINCIPAL_INVESTIGATOR
Hospital Group of the Catholic Institute of Lille
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital Group of the Catholic Institute of Lille
Lomme, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2015-A01451-48
Identifier Type: OTHER
Identifier Source: secondary_id
RC-P0043
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.